FADS2 and myocardial infarction: In 2007, Baylin et al. analyzed the effect of a common deletion variant in the Fads2 promoter (rs3834458) on ALA concentrations in adipose tissue and the risk of nonfatal myocardial infarction (MI) in a Costa Rican population of men and women diagnosed as survivors of a first acute MI [58].